In this talk, we will show how ELEM Biotech (http://elem.bio), a spinoff company of the Barcelona Supercomputing Center, is developing Virtual Humans to decisively contribute
to develop new therapeutical strategies, helping to personalize and optimize them. We are highly focused on cardiovascular and respiratory diseases, but in the talk we will show some results on other organs and systems. Virtual Humans are combinations of mathematical models and patient's data, which deployed in the cloud in High Performance instances, can predict the outcome of the therapy. We will show how ELEM technology allows us to create a population of such avatars to perform in-silico clinical trials.

If you would like to attend the seminar, please register here.